DGAP-Adhoc

H&R Aktiengesellschaft publishes good preliminary 9-month figures 2015 - Seite 2

The ChemPharm Refining segment made a significant contribution to the
improvement in the earnings situation, despite costs of raw materials
leading to a drop of 20.3% in revenues to EUR482.6 m. Of this amount,
EUR147.0m corresponded to the third quarter of 2015 (same nine months of
2014: EUR605.3m; Q3-2014: EUR195.5m). EBITDA of EUR41.3m, of which
EUR12.8m was accounted for by the third quarter of 2015, was likewise
significantly higher than the previous year's figure (same nine months of
2014: EUR18.9m; Q3-2014: EUR8.2m). The good pricing situation of our main
and secondary products was particularly influential in this respect.

The international activities forming part of our ChemPharm Sales segment
were reflected in this year's third-quarter figure of EUR82.1m (and
EUR247.4m in the first nine months of 2015), thereby representing a clear
increase in turnover (Q3-2014: EUR58m; same nine months of 2014:
EUR169.3m). EBITDA of EUR25m, of which EUR10.3m was accounted for by the
third quarter of 2015 alone, was likewise significantly higher than the
previous year's EBITDA figure (same nine months of 2014: EUR10.4m; Q3-2014:
EUR3.6m).

The plastics segment delivered sales of EUR14.0m in the course of the
quarter, and EUR45.8m over the nine-month period (Q3-2014: EUR14.0m; same
nine months of 2014: EUR41.2m), and represented this year - with respect to
the figure of the same period the previous year (Q3-2014: EUR0.2m; same
nine months of 2014: -EUR0.9m) a slightly improved EBITDA of -EUR0.2m
(Q3-2015: -EUR0.5m).

Operating cash flow for the third quarter of 2015 came to EUR12.2m
(Q3-2014: EUR14.0m), while the figure for free cash flow was EUR8.5m
(Q3-2014: EUR9.5m). On an annual-comparison basis, operating cash flow
rose, thanks to improved earnings and a lower net working capital
requirement, from -EUR18.3m to EUR32.1m, while free cash flow improved from
-EUR30.5m to EUR18.6m.

The balance-sheet total dropped, in comparison to the start-of-year figure
of EUR706.6m, to EUR675.2 m. Equity increased over the same period, from
EUR248.9m to EUR294.2m. As 30th September 2015 saw, for the first time, two
periods of comparison which took fully into account the changes arising
from the September 2014 increase in capital, the difference is apparent on
the 2015 reporting date are considerably less than those of the previous
quarters.

The expectations of the company H&R Aktiengesellschaft for the final
quarter of 2015 include at least a solid contribution to earnings, despite
a certain drop in commercial dynamism towards the end of the year. The
company expects, in purely operational terms and even in the event of